Enhanced Luminescence-Based Ion Beam Therapy System
Legal Citation
Summary of the Inventive Concept
An advanced radiation therapy system that leverages real-time luminescence emission feedback to optimize ion beam delivery, ensuring precise targeting of cancerous tissue while minimizing radiation exposure to healthy tissue.
Background and Problem Solved
Conventional radiation therapy methods often struggle with accurate targeting and radiation exposure control. The original patent's luminescence-based method for precise delivery of ion beam therapy has inherent limitations, such as lack of real-time feedback and limited radiation dose control. This new inventive concept addresses these limitations by integrating a luminescence-based detector and control unit to adjust the ion beam trajectory and intensity in real-time.
Detailed Description of the Inventive Concept
The system comprises a EuD4TEA-inclusive marker, a luminescence-based detector, and a control unit. The marker is placed on the patient's skin, and the ion beam is directed towards it. The detector measures the luminescence emission from the marker in real-time, providing feedback to the control unit. The control unit adjusts the ion beam trajectory and intensity based on the measured luminescence emission, ensuring accurate targeting of the cancerous tissue and minimizing radiation exposure to healthy tissue. This real-time feedback loop enables precise and controlled radiation delivery.
Novelty and Inventive Step
The new claims introduce a novel combination of a luminescence-based detector and control unit, enabling real-time adjustment of the ion beam trajectory and intensity. This integration provides a significant improvement over the original patent's method, which lacked real-time feedback and radiation dose control.
Alternative Embodiments and Variations
Alternative embodiments may include using different types of luminescent markers or detectors, integrating the system with existing radiation therapy gantries, or developing miniaturized versions of the system for more precise radiation delivery.
Potential Commercial Applications and Market
The enhanced luminescence-based ion beam therapy system has significant commercial potential in the radiation oncology market, offering improved treatment outcomes, reduced side effects, and increased patient safety. The system can be marketed to hospitals, cancer centers, and radiation therapy providers, with potential applications in treating various types of cancer.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Radiation oncology and medical imaging technologies, specifically ion beam therapy systems with luminescence-based targeting and monitoring techniques. Requires advanced knowledge of radiation physics, medical imaging, detector systems, and precision medical instrumentation.
Person of Ordinary Skill (PHOSITA) Profile
A skilled practitioner with a PhD or equivalent professional experience in medical physics, radiation oncology, or biomedical engineering, possessing expertise in radiation delivery systems, detector technologies, and real-time feedback mechanisms for medical interventions.
Obviousness Rationale
A PHOSITA would recognize that integrating real-time luminescence feedback and adaptive beam control represents a natural technological progression from the source patent's foundational luminescence-based ion beam therapy method. The PTD's claims extend the original concept by adding a control system that dynamically adjusts radiation delivery, which would be an expected optimization for precision medical treatments. The technical elements are fundamentally compatible and represent incremental improvements using standard engineering design approaches.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,806 |
|---|---|
| Title | Luminescence-based method for precise delivery of ion beam therapy |
| Assignee(s) | United States of America as represented by the Secretary of the Navy |